Tokyo Tape
Sign in

Daiichi Sankyo

4568.TPharmaceutical
Key numbers · FY ended 2026-03
Revenue¥2.12T+12.6% YoYOperating income¥258.0bn-22.3% YoYNet income (owners)¥279.7bn-5.4% YoYTotal assets¥4.00T+15.6% YoYEPS (basic)¥151.17-3.1% YoY

Full financial history and reports →

Stock price4568 · View chart ↗

Open the price chart on TradingView.

Latest filings
Fri, May 8 · JST1 filing
16:45MATERIALDaiichi Sankyo · Event with a material impact on financial position
Wed, Mar 4 · JST1 filing
11:03MATERIALDaiichi Sankyo · Change of representative director
Wed, Apr 9 · JST1 filing
15:37MATERIALDaiichi Sankyo · Change of representative director

All filings →

Major holders (5%+) · 0
HolderStakeChangeFiled

No holder currently reports 5% or more.

Each holder's own ratio from its most recent large-shareholding report.